Company / CapEx per Share
REGENXBIO Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.05
FY2025
5-year range
$0.05 / $0.72
FY2021-FY2025
Trend
-11.9%
vs FY2024
Sector context
#77 of 192
Health Care
What the data says
At $0.05, REGENXBIO Inc.'s capex per share ranks #77 of 192 in the Health Care sector. CapEx per Share has declined for 3 consecutive years, from $0.72 in FY2022 to $0.05 in FY2025.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of -32.9%.
Declined from $0.23 to $0.05 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -59.2%
- 5-Year CAGR
- -32.9%
- 10-Year CAGR
- -
Sector benchmark
#77 of 192 in Health CareTop 40% of 192This company $0.05 Sector average $2.46
▼
-98.0% below sector average
Key checks
Key Insights
- REGENXBIO Inc.'s capex per share has declined for 3 consecutive years.
- In FY2025, capex per share decreased 11.9% year-over-year.
- Ranks #77 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | -11.9% |
| FY2024 | $0.06 | -76.0% |
| FY2023 | $0.23 | -67.9% |
| FY2022 | $0.72 | +129.4% |
| FY2021 | $0.31 | -12.9% |
| FY2020 | $0.36 | +81.1% |
| FY2019 | $0.20 | -53.3% |
| FY2018 | $0.42 | +56.9% |
| FY2017 | $0.27 | +1263.2% |
| FY2016 | $0.02 | -89.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026